Sleep
Melatonin Benefits and Side Effects: A Functional-Medicine Lens on Causes and Support
Millions of people reach for melatonin when sleep falls apart — but most are guessing at the dose, ignoring the root cause, and overlooking real side-effect risks. A functional-medicine approach to melatonin goes far beyond the drugstore bottle: it asks why your body isn't making enough in the first place, and builds support around the actual data.

Why Melatonin Is More Than a Sleep Pill
Melatonin is one of the most purchased supplements in the United States, yet it remains one of the most widely misused. Most people treat it like an over-the-counter sedative — pop a 10 mg gummy, fall asleep faster, done. The reality is far more nuanced, and a functional-medicine lens reveals why getting melatonin right matters well beyond a single night's rest.
Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone synthesized primarily in the pineal gland from serotonin, which itself depends on tryptophan, B6, and adequate light-dark signaling. Its secretion follows a tightly regulated circadian rhythm: levels begin rising roughly two hours before habitual sleep onset, peak between 2–4 a.m., and fall sharply at dawn. That rhythm is the body's master clock signal — coordinating core body temperature, cortisol release, immune activity, and even gut motility.
When that rhythm breaks down — through blue-light overexposure, shift work, alcohol, stress, or simple aging — the downstream effects extend far beyond insomnia. Understanding the full spectrum of melatonin benefits and side effects is the first step toward using it intelligently.
---
The Evidence-Backed Benefits of Melatonin
Circadian Rhythm Resynchronization
The strongest clinical evidence for melatonin isn't in primary insomnia — it's in circadian misalignment. A meta-analysis of 10 randomized trials found that low-dose melatonin (0.5–3 mg) taken at a consistent time reduced sleep-onset latency and advanced the dim-light melatonin onset (DLMO) in jet-lag and delayed sleep-phase syndrome patients (Brzezinski et al., Sleep Medicine Reviews, 2005; PMID: 15589266). This phase-shifting effect is dose- and timing-sensitive: taking melatonin at the wrong circadian phase can actually worsen alignment.
Sleep Quality and Latency in Older Adults
Endogenous melatonin production declines significantly with age — by some estimates, adults over 60 produce 50–75% less than younger adults (NIH National Institute on Aging). Several controlled trials demonstrate that physiological doses (0.3–1 mg) more closely mimic natural secretion and improve sleep efficiency in older adults without next-day grogginess, unlike higher pharmacological doses. A Cochrane-adjacent review of 19 trials confirmed melatonin's superiority over placebo for reducing sleep-onset latency by an average of 7.06 minutes, a modest but clinically meaningful effect in the context of chronic sleep disruption (Ferracioli-Oda et al., PLOS ONE, 2013; PMID: 23691095).
Antioxidant and Mitochondrial Protection
Less discussed but equally important: melatonin is a potent direct free-radical scavenger, neutralizing hydroxyl radicals without becoming pro-oxidant itself. Preclinical and emerging clinical data suggest it protects mitochondrial function and may reduce oxidative stress markers in cardiovascular and metabolic contexts (Reiter et al., Acta Biochimica Polonica, 2003; PMID: 12673349). This makes melatonin of interest in functional protocols for cardiovascular and metabolic support — an area where clinical evidence for CoQ10 and mitochondrial health often overlaps.
Immune Modulation
Melatonin receptors (MT1 and MT2) are expressed on natural killer cells, T-lymphocytes, and monocytes. Research suggests melatonin plays an immunomodulatory role, enhancing innate immune responses during low-melatonin states while dampening excess inflammation — a bidirectional effect that mirrors its circadian function (Carrillo-Vico et al., International Immunopharmacology, 2005; PMID: 15652755). Functional practitioners increasingly consider melatonin as part of immune-resilience protocols, particularly for patients with disrupted sleep-immune axes.
---
Melatonin Side Effects: The Real Clinical Picture
Melatonin is generally well-tolerated at low doses for short-term use, but the evidence on long-term safety at high doses is thin, and the side-effect profile is frequently underreported.
Common side effects (particularly at doses above 3 mg):
- Next-day grogginess or "sleep inertia"
- Vivid dreams or nightmares
- Headache
- Dizziness
- Mild hypothermia (core body temperature drop)
Less common but important concerns:
- Suppression of endogenous production: Chronic supplementation with pharmacological doses may downregulate pineal output, though robust human data are limited (NIH Office of Dietary Supplements).
- Hormonal interactions: Melatonin influences luteinizing hormone (LH) and prolactin secretion. High-dose use in reproductive-age individuals warrants caution, particularly in those managing thyroid or endocrine conditions.
- Drug interactions: Melatonin potentiates CNS depressants (benzodiazepines, alcohol), anticoagulants (warfarin), and immunosuppressants. Patients on any of these medications should consult a healthcare provider before supplementing.
- Paradoxical alertness: At doses above 5–10 mg, some individuals experience counter-intuitive activation, likely due to receptor saturation and downstream serotonergic effects.
The practical takeaway: the most common mistake is dosing too high. The optimal clinical dose for most adults seeking circadian support is 0.5–3 mg, not the 5–10 mg products dominating retail shelves.
| Dose Range | Primary Use | Side-Effect Risk |
|---|---|---|
| 0.3–0.5 mg | Circadian phase-shifting, older adults | Very low |
| 1–3 mg | Sleep-onset latency, jet lag | Low |
| 5–10 mg | Occasionally studied in specific conditions | Moderate — next-day grogginess, hormonal effects |
| >10 mg | No strong clinical basis for most adults | Higher — receptor saturation, paradoxical effects |
---
Root Causes of Low Melatonin: The Functional-Medicine Workup
A functional-medicine approach doesn't start with a supplement — it starts with the question: why is melatonin production impaired in the first place?
Key upstream drivers of low endogenous melatonin:
- Light exposure dysregulation — Artificial blue light (400–490 nm) suppresses melatonin synthesis by up to 85% at night (Harvard Medical School, Division of Sleep Medicine). Evening screen use is the most modifiable factor.
- Cortisol excess / HPA axis dysregulation — Elevated nighttime cortisol directly antagonizes melatonin secretion. This is the most overlooked root cause in high-achieving, high-stress individuals. Supporting adrenal function is often the prerequisite for melatonin to work. Understanding how adaptogenic herbs support the HPA axis and cortisol balance is foundational here.
- Nutrient deficiencies — Melatonin synthesis requires tryptophan → 5-HTP → serotonin → N-acetylserotonin → melatonin. Rate-limiting cofactors include Vitamin B6 (P5P form), magnesium, and zinc. A deficiency in any of these can blunt output regardless of supplementation.
- Age-related pineal calcification — Progressive calcification of the pineal gland reduces secretory capacity. This is biologically normal but accelerated by chronic inflammation and poor mineral status.
- Gut dysbiosis — The gut produces roughly 400 times more serotonin than the brain; disrupted gut flora impairs serotonin availability, which limits the substrate for melatonin synthesis.
This systems-level view is why high-quality personalized supplement platforms like Ones analyze wearable data (including sleep-stage metrics and HRV), blood biomarkers, and health history together — because no single biomarker tells the whole melatonin story.
---
Secondary Ingredients Worth Knowing in Sleep and Metabolic Formulas
When exploring evidence-based sleep and metabolic health supplements, you'll often encounter a cluster of ingredients that appear alongside melatonin in functional protocols. Understanding the evidence — and limitations — of each is part of making informed choices.
What to Know About Phosphatidylcholine and Sleep-Adjacent Health
Phosphatidylcholine (PC) is a phospholipid central to cell membrane integrity and the primary dietary source of choline, which is a precursor to acetylcholine — a neurotransmitter involved in REM sleep regulation. Research in older adults suggests choline insufficiency correlates with disrupted sleep architecture, particularly reduced REM duration (NIH Office of Dietary Supplements, Choline Fact Sheet). Supplemental phosphatidylcholine is generally well-tolerated; reported side effects at higher doses include fishy body odor (due to TMAO conversion), mild gastrointestinal upset, and, rarely, nausea. Individuals with trimethylaminuria should avoid high-dose PC. For most people seeking optimal choline intake and cognitive support, PC supplementation at 500–2,000 mg/day has a reasonable safety profile and may support both cognitive function and hepatic fat metabolism.
Artichoke Extract: Liver Support and Its Relevance to Hormone Clearance
Artichoke leaf extract (Cynara scolymus) is primarily studied for its hepatoprotective and lipid-modulating effects. A randomized controlled trial in 143 adults with non-alcoholic fatty liver disease found that artichoke extract (600 mg/day for two months) significantly reduced ALT and AST liver enzyme levels compared to placebo (Rangboo et al., International Journal of Molecular and Cellular Medicine, 2016; PMID: 27386460). This matters in a melatonin context because liver health directly governs hormone clearance — including estrogen metabolism and cortisol conjugation, both of which affect melatonin rhythm. Artichoke extract side effects are generally mild and transient: bloating, flatulence, and in rare cases allergic reactions in individuals sensitive to the Asteraceae family. Ones includes artichoke-related liver-support compounds in its proprietary Liver Support System Blend, which is particularly relevant for individuals whose bloodwork flags elevated liver enzymes alongside sleep disruption.
Pea Protein: Sleep-Adjacent Nutrition and Gut Health
Pea protein isolate has grown in popularity as a plant-based protein source, and its relevance to sleep is indirect but real: adequate dietary protein supports tryptophan availability, the precursor to both serotonin and melatonin. Pea protein is rich in arginine and branched-chain amino acids, has a PDCAAS of approximately 0.89, and is well-studied for muscle-protein synthesis support. Reported pea protein side effects are generally gastrointestinal — bloating, gas, and GI discomfort — due to oligosaccharide content. These are typically dose-dependent and reduced with slower titration. Pea protein has no known hormonal interactions, making it a reasonable choice for individuals on melatonin or hormone-adjacent protocols. For those focused on building a protein strategy that supports sleep and recovery, pairing pea protein with tryptophan-rich whole foods at dinner may modestly support endogenous melatonin synthesis.
---
How Ones Addresses This: Building a Personalized Sleep Formula
A personalized approach to sleep support doesn't begin with melatonin — it begins with data. Ones analyzes your blood work (including cortisol markers, B-vitamin status, thyroid panel, and inflammatory markers), wearable sleep data, and health history to identify which upstream drivers are most relevant to your specific sleep disruption.
Depending on your profile, a Ones formula might include:
- Magnesium Glycinate (Magnesium Complex blend): Magnesium activates GABA receptors, lowers nocturnal cortisol, and is a required cofactor in melatonin synthesis. A randomized trial in older adults with insomnia found that 500 mg/day of magnesium for eight weeks significantly improved sleep efficiency, sleep time, and early morning awakening (Abbasi et al., Journal of Research in Medical Sciences, 2012; PMID: 23853635). Ones includes magnesium glycinate as part of its Magnesium Complex blend — glycinate being the form with the highest bioavailability and lowest GI side-effect burden.
- Ashwagandha KSM-66 (600 mg): For individuals whose sleep disruption is driven by HPA axis dysregulation, ashwagandha addresses the cortisol-melatonin antagonism directly. A double-blind RCT in 60 adults found that KSM-66 at 300 mg twice daily (600 mg/day) over eight weeks significantly improved sleep quality (PSQI scores), sleep onset, and sleep efficiency compared to placebo (Langade et al., PLOS ONE, 2019; PMID: 31728244). Ones includes KSM-66 ashwagandha at this validated 600 mg clinical dose for individuals with elevated evening cortisol on wearable or lab data.
- Vitamin D3 + K2 (MK-7): Vitamin D insufficiency is strongly associated with poor sleep quality and reduced melatonin amplitude. A systematic review of 9 studies found inverse associations between vitamin D status and sleep disorders, with deficiency correlating with shorter sleep duration (Gao et al., Nutrients, 2018; PMID: 30072673). Ones pairs D3 with K2 in MK-7 form to support calcium partitioning — including reducing pineal calcification risk — and delivers both at clinically relevant doses calibrated to your individual D3 blood level.
For individuals with wearable data showing poor HRV or fragmented sleep alongside elevated liver enzyme markers, Ones may also recommend its Liver Support System Blend and Adrenal Support System Blend in combination — because melatonin rhythm restoration often requires multiple systems working in concert.
---
Melatonin vs. Personalized Sleep Stacks: A Platform Comparison
| Feature | OTC Melatonin | Thorne | Ritual | Ones |
|---|---|---|---|---|
| Dose precision | Fixed (often too high) | Practitioner calibrated | Standardized multi | Calibrated to your data |
| Root-cause analysis | None | Partial (practitioner-led) | None | AI + lab + wearable |
| Cofactor support (Mg, B6, D3) | Rarely included | Available separately | Limited | Bundled per biomarker gaps |
| Hormonal context considered | No | Depends on practitioner | No | Yes (cortisol, thyroid, D3) |
| Personalization depth | None | Moderate | Low | High |
---
Key Takeaways
- Melatonin is a circadian hormone, not a sedative — its benefits are most pronounced for circadian misalignment (jet lag, shift work, DSPD), not primary insomnia, and the optimal dose for most adults is 0.5–3 mg, not 10 mg.
- Side effects are dose-dependent: Next-day grogginess, hormonal interactions, and potential suppression of endogenous production are real risks at pharmacological doses — and largely avoidable with appropriate dosing.
- Root causes matter more than supplementation: Blue-light exposure, HPA axis dysregulation, nutrient deficiencies (B6, magnesium, zinc), and gut dysbiosis all suppress endogenous melatonin production and must be addressed upstream.
- Cofactor ingredients — magnesium glycinate, Vitamin D3+K2, ashwagandha KSM-66 — often provide more durable sleep support than melatonin alone, particularly when personalized to biomarker data.
- Secondary ingredients like phosphatidylcholine and artichoke extract support hormone clearance and neurotransmitter pathways that influence sleep architecture, making them relevant in comprehensive functional sleep protocols.
- A personalized platform like Ones that integrates blood work, wearable sleep data, and health history can identify which combination of ingredients — at which doses — addresses your specific sleep disruption pattern, rather than guessing at the pharmacy.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any supplement regimen, particularly if you are pregnant, nursing, taking prescription medications, or managing a diagnosed sleep disorder.